<DOC>
	<DOCNO>NCT02329821</DOCNO>
	<brief_summary>The investigator try investigate metabolism lactate source IV Hartmann 's solution patient hepatocellular carcinoma ( HCC ) compare control group ( donation liver transplantation ) normal liver function . Second purpose study find predictive factor change metabolism lactate source IV Hartmann 's solution patient HCC .</brief_summary>
	<brief_title>Change Lactate Concentration During Hartmann Solution Infusion Hepatic Resection</brief_title>
	<detailed_description>The liver important acid-base physiology electrolyte balance . It important metabolically active organ may either significant net producer consumer hydrogen ion . Lactate produce peripheral tissue muscle , skin , brain , red blood cell metabolize predominantly liver kidney , first pyruvate secondly glucose . In healthy liver , net-uptake lactate cause gluconeogenesis , liver exhibit high net lactate clearance organ anticipate 70 % whole body clearance . Lactic acidosis result hepatic metabolism adequate . Hartmann 's solution , contain 28 mmol/l lactate pH 6.5 , extensively use maintain replace intravascular volume variety anesthetic procedure . Excessive use saline observe result hyperchloraemic acidosis - identify potential side effect saline base solution . It suggest use balance electrolyte solution may avoid effect . A previous study concern normal saline , contain lactate , might detrimental liver donor association hyperchloremic metabolic acidosis . Metabolism lactate source IV Hartmann 's solution also result net consumption H+ , lactate associate Na+ , overall result net bicarbonate production . Effectively , metabolism lactate result generation equivalent amount bicarbonate . The investigator evaluate metabolism lactate source IV Hartmann 's solution patient HCC donor liver transplantation ( control group ) . All patient underwent multiple medical assessment surgery , include routine laboratory test ( complete blood count , standard liver renal function test , coagulation test , viral serology ) , electrocardiography , chest X-ray , hepatobiliary imaging , percutaneous liver biopsy , indocyanine green retention testing ( ICG test ) . Hartmann solution ( Hartmann , Choongwae pharmaceutical , Seoul , Korea ) solution compose 130 mmol/l sodium,109 mmol/l chloride , 4 mmol/l potassium,1.5 mmol/l calcium , 28 mmol/l lactate , pH 6.5 . Briefly , anesthesia induce thiopental sodium ( 5 mg/kg ) , vecuronium ( 0.15 mg/kg ) . Endotracheal intubation perform , general anesthesia maintain sevoflurane ( 2-3 vol % 50 % air oxygen ) . Throughout surgery , patient monitor electrocardiography , pulse oximetry , capnography , esophageal temperature , invasive arterial pressure ( via radial artery catheter ) . Fluid administration ( Hartmann solution ) begin upon arrival operating room 5ml/kg/hour rate . Acid-base status lactate , electrolyte , hemoglobin concentration assess immediately 2 hour induction anesthesia . The infusion rate fluid 5ml/kg/hour . The reason rate intravenous crystalloid administration restrict hepatic dissection request surgeon investigator consider requirement fluid loss . Mean arterial blood pressure &gt; 60mmHg urine output &gt; 0.5 ml/kg/h maintain anesthesia . When mean arterial blood pressure &lt; 60 mmHg , volume fluid administer increase initially and/or intravenous ephedrine ( 5-10 mg ) inject , appropriate . If maintain hemodynamic stability need fluid administration , investigator manage fluid administration inotropics , case withdrawn . Duration 2 hour , volume Hartmann solution result arterial blood gas analysis ( Acid-base status lactate , electrolyte , hemoglobin concentration assess immediately 2 hour induction anesthesia ) record . The investigator compare change lactate level patient HCC control group ( donation liver transplantation ) normal liver function . After evaluate metabolism exogenous lactate , investigator try find predictive factor ( among liver profile lab , MELD score , INR , functional liver volume , ICG test ) change metabolism lactate source IV Hartmann 's solution patient HCC .</detailed_description>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>patient hepatocellular carcinoma patient diabetic mellitus patient electrolyte inbalance patient renal failure</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>lactate</keyword>
	<keyword>hartmann solution</keyword>
	<keyword>hepatocellular carcinoma</keyword>
</DOC>